These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27140447)
1. Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin. Matignon M; Leibler C; Moranne O; Salomon L; Charron D; Lang P; Jacquelinet C; Suberbielle C; Grimbert P Clin Transplant; 2016 Jun; 30(6):731-40. PubMed ID: 27140447 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
3. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
4. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration. Kimball PM; McDougan FA; King A Clin Transpl; 2014; ():197-203. PubMed ID: 26281145 [TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study. Matignon M; Pilon C; Commereuc M; Grondin C; Leibler C; Kofman T; Audard V; Cohen J; Canoui-Poitrine F; Grimbert P PLoS One; 2017; 12(6):e0178572. PubMed ID: 28654684 [TBL] [Abstract][Full Text] [Related]
6. Anti-human leukocyte antigen immunization after early allograft nephrectomy. Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471 [TBL] [Abstract][Full Text] [Related]
10. Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Del Bello A; Congy-Jolivet N; Sallusto F; Guilbeau-Frugier C; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Blancher A; Rostaing L; Kamar N Clin J Am Soc Nephrol; 2012 Aug; 7(8):1310-9. PubMed ID: 22626959 [TBL] [Abstract][Full Text] [Related]
11. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854 [TBL] [Abstract][Full Text] [Related]
12. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure. Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228 [TBL] [Abstract][Full Text] [Related]
13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]